Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro

Background: Apigenin, a flavonoid phytochemical extracted from fruits and vegetables, has shown anti-neoplastic effects in a variety of malignant tumors. DLBCL is the most common type of aggressive lymphoma in adults with a poor prognosis. Small-molecule inhibitors like BTK inhibitors have demonstra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Huang, Shujuan, Yu, Mengxia, Shi, Nana, Zhou, Yile, Li, Fengling, Li, Xia, Huang, Xin, Jin, Jie
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052937/
https://ncbi.nlm.nih.gov/pubmed/32127939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34981
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares